Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "2015 Emerging Molecular Immunohematology Blood Typing Grouping Infectious" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about 2015 Emerging Molecular Immunohematology Blood Typing Grouping Infectious for you to read. Along with our medical data and news we also list 2015 Emerging Molecular Immunohematology Blood Typing Grouping Infectious Clinical Trials, which are updated daily. BioPortfolio also has a large database of 2015 Emerging Molecular Immunohematology Blood Typing Grouping Infectious Companies for you to search.
In 2014, a few days before Christmas, seven children, including an unvaccinated 11-year old, were hospitalised with measles following their visit to a theme park in Orange County, CA, USA. By February 2015, the US Center for Disease Control and Prevention had recorded more than 100 cases of measles and traced the origin of the outbreak back to the theme park. The majority of patients were either u...
In The Lancet Infectious Diseases, authors led by the Institute of Health Metrics and Evaluation (University of Washington, Seattle, WA, USA) add to our understanding of enteric fevers by presenting a comprehensive and systematic analysis of the global burden of typhoid and paratyphoid fevers using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017.1 Unlike previo...
Developing Sample to Insight solutions to accelerate research on growing public health threat QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V. (Euronext: CURE), to develop innovative bioinformatics and assay solutions to accelerate research targeting the growing g...
SummaryThe global Hepatitis Diagnostic Test market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included based on ...
DUBLIN–(BUSINESS WIRE)–The “Tygacil – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Tygacil Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the … Continue reading →
DUBLIN–(BUSINESS WIRE)–The “Xopenex – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Xopenex Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the … Continue reading →
DUBLIN–(BUSINESS WIRE)–The “Diprivan EML- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Diprivan EML Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers … Continue reading →
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Simvastatin Market, 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The blood lipid levels of Chinese people are rising as China’s economy develops and a high-calorie and high-fat diet becomes increasingly prevalent. In 2018, … Continue reading →
#Cancer Spread and Blood Clots May Be Halted by Platelet Decoys: http://ow.ly/ghVW30nHIXe pic.twitter.com/npNaP30gHF
DUBLIN–(BUSINESS WIRE)–The “Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends” report has been added to ResearchAndMarkets.com’s offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. This emerging treatment represents one of the biggest … Continue reading →
Vizient today announced its support for the Advancing Care for Exceptional (ACE) Kids Act. The bipartisan ACE Kids Act would expand care options and promote enhanced care coordination for children who have complex medical needs. In letters to the lead sponsors in the House and Senate, Vizient has offered our formal endorsement of the ACE Kids Act. ...
Sarah B. Goldberg, MD, MPH, sheds light on the complex treatment paradigm for patients with lung cancer who have central nervous system metastases and highlights emerging treatment strategies for those with mesothelioma.
Laura J. Esserman, MD, MBA, a 2018 Giants of Cancer Care® award winner in the Cancer Diagnostics category led the way in designing the I-SPY clinical trials, a groundbreaking effort to match patients with breast cancer to potential therapies based on molecular drivers of disease. She also has advocated for a greater understanding of the biological drivers of breast cancer, rather than relying ...
Telemedicine holds great promise to address a wide range of health issues in Latin America. Yet its use hasn’t reached broad national and regional levels. Research from Florida International University’s College of Business (FIU Business) indicates that increased adoption of telemedicine in Latin America will further expand and boost ef...
Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The Fenwal Amicus RBCx system allows for the The post Fresenius Kabi gets 510(k) clearance for Fenwal Amicus red blood cell exchange protocol appeared first on Compelo Medical Devices.
The study was conducted by the scientists at the University of Leicester along with the MRC Toxicology Unit, now part of the University of Cambridge. The study found The post Research suggests simple blood test may enhance early detection of lung cancer appeared first on Compelo Medical Devices.
This study used U.S. population data to identify changes in the supply of primary care physicians across counties from 2005 to 2015 and the association with life expectancy and other outcomes.
Houston Methodist infectious disease scientists have discovered a previously unknown trigger that turns a relatively run-of-the-mill infection into a devastatingly ravenous, flesh-eating disease.